US Broker Ratings

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Unlocking a 30.99% Potential Upside Amidst Biotech Volatility

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) has captured the attention of investors in the biotechnology sector, a notoriously volatile yet potentially rewarding industry. With a market capitalization of $1.78 billion, Sarepta..

Soleno Therapeutics, Inc. (SLNO)

⚠️ No article content returned.

..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Exploring a 43% Potential Upside in Biotech Innovation

Roivant Sciences Ltd. (NASDAQ: ROIV) stands at the intersection of biotechnology innovation and investor interest with its ambitious pipeline and strategic focus on unmet medical needs. With a market capitalization..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: Navigating a 66.8% Revenue Growth in Biotech

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is making waves in the healthcare sector, particularly within the biotechnology industry. With its focus on rare neuroendocrine diseases, Rhythm’s lead product, IMCIVREE (setmelanotide), is..

BrightSpring Health Services, Inc. (BTSG) Stock Analysis: Exploring a 21.18% Upside Potential in the Healthcare Sector

BrightSpring Health Services, Inc. (NASDAQ: BTSG) is capturing the attention of individual investors with its promising growth metrics and compelling analyst ratings. Operating within the healthcare sector, specifically in the..

Moderna, Inc. (MRNA) Stock Analysis: Evaluating the 88.67% Potential Upside

Moderna, Inc. (NASDAQ: MRNA), a biotechnology powerhouse renowned for its pioneering work in messenger RNA (mRNA) medicines, is currently navigating a complex financial landscape. With a market capitalization of $9.37..

TG Therapeutics, Inc. (TGTX) Stock Analysis: A Look at the 38% Potential Upside

TG Therapeutics, Inc. (NASDAQ: TGTX) stands as a noteworthy player in the biotechnology sector, specializing in innovative treatments for B-cell mediated diseases. With a market capitalization of $4.65 billion, this..

Bruker Corporation (BRKR) Stock Analysis: Unveiling a 37.51% Potential Upside for Investors

Investors looking into the healthcare sector, particularly within the medical devices industry, should not overlook Bruker Corporation (NASDAQ: BRKR). With a market capitalization of $5.16 billion, Bruker is a prominent..

Henry Schein, Inc. (HSIC) Stock Analysis: Exploring a 5.25% Potential Upside in the Healthcare Sector

For investors eyeing opportunities in the healthcare sector, Henry Schein, Inc. (NASDAQ: HSIC) presents an intriguing proposition. With its headquarters in Melville, New York, this medical distribution giant has been..

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: Exploring a 21.69% Upside Potential

Investors seeking opportunities in the healthcare sector might find Prestige Consumer Healthcare Inc. (NYSE: PBH) a compelling option. With a market capitalization of $3.35 billion, Prestige Consumer Healthcare stands as..

Alkermes plc (ALKS) Stock Analysis: Exploring a 43.25% Upside Potential with a Strong Buy Consensus

Investors eyeing opportunities in the healthcare sector may find Alkermes plc (NASDAQ: ALKS) an intriguing prospect. With its roots firmly planted in Dublin, Ireland, this biopharmaceutical company boasts a rich..

Chemed Corp (CHE) Stock Analysis: Exploring a Potential 23.87% Upside in the Healthcare Sector

Chemed Corp (CHE), a stalwart in the healthcare sector, is drawing investor attention with a notable potential upside of 23.87%, according to analyst ratings. With a current market cap of..

IQVIA Holdings, Inc. (IQV) Stock Analysis: Investor Outlook with a 12.71% Upside Potential

IQVIA Holdings, Inc. (NYSE: IQV), a prominent player in the healthcare sector, specifically within the diagnostics and research industry, stands out as a significant investment opportunity. With a market capitalization..

Exelixis, Inc. (EXEL) Stock Analysis: Navigating the Biotech Giant’s 19.55% Potential Upside

Exelixis, Inc. (NASDAQ: EXEL) stands at the forefront of the biotechnology sector with a market capitalization of $10.07 billion, positioning itself as a prominent player in the healthcare industry. Focusing..

Becton, Dickinson and Company (BDX) Stock Analysis: Assessing a 7.78% Upside Potential in the Healthcare Sector

Becton, Dickinson and Company (NYSE: BDX) stands as a formidable player in the healthcare sector, particularly within the medical instruments and supplies industry. With a robust market capitalization of $55.31..

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: Eyeing a 5.39% Upside Amidst Revolutionary Biotech Innovations

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) sits at an intriguing juncture for investors, presenting a combination of promising scientific advancements and complex financial metrics. As a biotech company specializing in innovative..

Incyte Corporation (INCY) Stock Analysis: Navigating the Biotech Frontier with Strong Revenue Growth

Incyte Corporation (NASDAQ: INCY) stands as a notable player in the biotechnology sector, offering a robust portfolio of therapeutic products across various markets including the United States, Europe, Canada, and..

HealthEquity, Inc. (HQY) Stock Analysis: Strong Buy Ratings and 36% Potential Upside Make It a Healthcare Gem

HealthEquity, Inc. (HQY) is a prominent player in the health information services industry, offering technology-enabled platforms that are revolutionizing the way consumers and employers manage health savings accounts and related..

Thermo Fisher Scientific Inc (TMO) Investor Outlook: Robust Growth Potential with a 12.36% Upside

Thermo Fisher Scientific Inc (TMO), a formidable player in the healthcare sector, has captured investor attention with its significant potential upside. As a leader in the diagnostics and research industry,..

Hologic, Inc. (HOLX) Stock Analysis: Navigating a 9% Potential Upside in the Healthcare Sector

Hologic, Inc. (HOLX) stands as a prominent player within the healthcare sector, specifically in the medical instruments and supplies industry. With a market capitalization of $14.93 billion, it has carved..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds